注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Myosin Light Chain 2 Recombinant Rabbit mAb   

Myosin Light Chain 2 Recombinant Rabbit mAb

     
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
WB
Reactivity Mouse
Predicted Rat, Human
Host Rabbit
Clonality Recombinant
Calculated MW 20 KDa
Physical State Liquid
Immunogen A synthesized peptide derived from human Myosin light chain 2
Epitope Specificity 100-166/166
Isotype IgG
Purity affinity purified by Protein A
Buffer 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
SIMILARITY Contains 3 EF-hand domains.
SUBUNIT Myosin is a hexamer of 2 heavy chains and 4 light chains.
Post-translational modifications N-terminus is methylated by METTL11A/NTM1.
DISEASE Defects in MYL2 are the cause of cardiomyopathy familial hypertrophic type 10 (CMH10) [MIM:608758]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Defects in MYL2 are the cause of cardiomyopathy familial hypertrophic with mid-left ventricular chamber type 2 (MVC2) [MIM:608758]. MVC2 is a very rare variant of familial hypertrophic cardiomyopathy, characterized by mid-left ventricular chamber thickening.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Background Descriptions Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]
Additional Information
Other Names MLC-2s/v; CMH10; MFM12; MLC-2; MLC-2v; MLC2; Gm32672; Mlc2v; Mylpc; MLRV_BOVIN; MYL2; Myosin light chain 2, slow skeletal/ventricular muscle isoform (MLC-2s/v); MLRV_HUMAN; Cardiac myosin light chain 2; Ventricular myosin light chain 2; MLRV_MOUSE; MLRV_RAT; myosin light chain 2; myosin, light polypeptide 2, regulatory, cardiac, slow; myosin, light chain 2, regulatory, cardiac, slow; cardiac ventricular myosin light chain 2
Dilution WB=1:500-2000
StorageStore at -20 °C for one year. Avoid repeated freeze/thaw cycles. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Name Myosin Light Chain 2 Recombinant Rabbit mAb
Function Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion.

For Research Use Only. Not For Use In Diagnostic Procedures.

Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价